{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T04:57:53Z","timestamp":1785560273942,"version":"3.56.0"},"reference-count":22,"publisher":"Japanese Society of Internal Medicine","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2026]]},"DOI":"10.2169\/internalmedicine.7502-26","type":"journal-article","created":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T22:11:33Z","timestamp":1785535893000},"source":"Crossref","is-referenced-by-count":0,"title":["Atypical Anorexia Nervosa Developed in a Patient with Severe Obesity and Type 2 Diabetes Following Sleeve Gastrectomy and Postoperative Treatment with Semaglutide and Tirzepatide"],"prefix":"10.2169","author":[{"given":"Chiaki","family":"Saito","sequence":"first","affiliation":[{"name":"Department of Endocrinology and Metabolism, Dokkyo Medical University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Saito","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Dokkyo Medical University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masatoshi","family":"Nakagawa","sequence":"additional","affiliation":[{"name":"Department of Upper Gastrointestinal Surgery, Dokkyo Medical University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshie","family":"Iijima","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Dokkyo Medical University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuya","family":"Tomaru","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Dokkyo Medical University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teruo","family":"Jojima","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Dokkyo Medical University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isao","family":"Usui","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Dokkyo Medical University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norio","family":"Yasui-Furukori","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Dokkyo Medical University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuyuki","family":"Kojima","sequence":"additional","affiliation":[{"name":"Department of Upper Gastrointestinal Surgery, Dokkyo Medical University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshimasa","family":"Aso","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Dokkyo Medical University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Uemura N, Nishida Y, Sasaki S, et al. BMI trajectory of 8,155,894 Japanese adults from exhaustive health checkup data: the contributions of age-related changes in height and weight. Int J Obes (Lond) 49: 742-745, 2025.","DOI":"10.1038\/s41366-024-01694-1"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. GBD 2015 Obesity Collaborators; Afshin A, et al. Health Effects of Overweight and Obesity in 195 Countries over 25 Years. N Engl J Med 377: 13-27, 2017.","DOI":"10.1056\/NEJMoa1614362"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Sarma S, Palcu P. Weight loss between glucagon-like peptide-1 receptor agonists and bariatric surgery in adults with obesity: A systematic review and meta-analysis. Obesity (Silver Spring). 30: 2111-2121, 2022.","DOI":"10.1002\/oby.23563"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Hebebrand J, Antel J, Concei\u00e7\u00e3o E, Matthews A, Hinney A, Peters T. What Amount of Weight Loss Can Entail Anorexia Nervosa or Atypical Anorexia Nervosa After Bariatric Surgery? Int J Eat Disord 57: 2461-2468, 2024.","DOI":"10.1002\/eat.24286"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Scioscia TN, Bulik CM, Levenson J, Kirby DF. Anorexia nervosa in a 38-year-old woman 2 years after gastric bypass surgery. Psychosomatics 40: 86-88, 1999.","DOI":"10.1016\/S0033-3182(99)71278-8"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Chu R, Desman J, Lynch H, Hill I, Devine G, Rice T. De novo anorexia nervosa post-bariatric surgery. Obes Res Clin Pract 19: 364-366, 2025.","DOI":"10.1016\/j.orcp.2025.06.005"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Abdallah H, Klink WH, Derienne J, et al. Interest in Treatment with GLP-1 Receptor Agonists for the Management of Insufficient Weight Loss or Weight Regain After Bariatric Surgery. Obes Surg 35: 4286-4291, 2025.","DOI":"10.1007\/s11695-025-08210-y"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Guerdjikova AI, Ward A, Ontiveros M, McElroy SL. Semaglutide Misuse in Atypical Anorexia Nervosa-A Case Report. J Clin Psychopharmacol 44: 179-180, 2024.","DOI":"10.1097\/JCP.0000000000001820"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Guerdjikova AI, Dlugosz H, Wolterman R, McElroy SL. Relapse in Anorexia Nervosa Associated With Tirzepatide: A Case Report. J Clin Psychopharmacol 45: 287-288, 2025.","DOI":"10.1097\/JCP.0000000000001975"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. American Psychiatric Association, Washington, DC, 2013.","DOI":"10.1176\/appi.books.9780890425596"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Vo M, Golden N. Medical complications and management of atypical anorexia nervosa. J Eat Disord 10: 196, 2022.","DOI":"10.1186\/s40337-022-00720-9"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Saiki A, Kanai R, Nakamura S, et al. Impact of Mental Health Background and Nutrition Intake on Medium-Term Weight Loss in Japanese Patients Undergoing Laparoscopic Sleeve Gastrectomy. Obes Facts 13: 371-383, 2020.","DOI":"10.1159\/000509342"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Walsh BT, Hagan KE, Lockwood C. A systematic review comparing atypical anorexia nervosa and anorexia nervosa. Int J Eat Disord 56: 798-820, 2023.","DOI":"10.1002\/eat.23856"},{"key":"14","doi-asserted-by":"crossref","first-page":"e70201","DOI":"10.1111\/jog.70201","volume":"52","author":"Y Tamura","year":"2026","unstructured":"14. Tamura Y, Ogawa W, Ishii K, et al.; Working Group on Female Underweight\/Undernutrition Syndrome, Japan Society for the Study of Obesity. Female Underweight\/Undernutrition Syndrome (FUS): An Emerging Health Concept in Premenopausal Women - Secondary Publication (English Translation of the Japanese Statement). J Obstet Gynaecol Res 52: e70201, 2026.","journal-title":"Journal of Obstetrics and Gynaecology Research","ISSN":"https:\/\/id.crossref.org\/issn\/1341-8076","issn-type":"print"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Concei\u00e7\u00e3o E, Orcutt M, Mitchell J, et al. Eating disorders after bariatric surgery: a case series. Int J Eat Disord 46: 274-279, 2013.","DOI":"10.1002\/eat.22074"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Watson C, Riazi A, Ratcliffe D. Exploring the Experiences of Women Who Develop Restrictive Eating Behaviours After Bariatric Surgery. Obes Surg 30: 2131-2139, 2020.","DOI":"10.1007\/s11695-020-04424-4"},{"key":"17","unstructured":"17. Brone RJ, Fisher CB. Determinants of adolescent obesity: a comparison with anorexia nervosa. Adolescence 23: 155-169, 1988."},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Wilding JPH, Batterham RL, Calanna S, et al.; STEP 1 Study Group. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med 384: 989-1002, 2021.","DOI":"10.1056\/NEJMoa2032183"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Kramer CK, Retnakaran M, Viana LV. Effect of Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) on Weight Loss Following Bariatric Treatment. J Clin Endocrinol Metab 109: e1634-e1641, 2024.","DOI":"10.1210\/clinem\/dgae176"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. He M, Wang Y, Hua R, et al. Short-Term Weight Loss Outcomes of 1.0 mg Semaglutide Therapy Initiated 6 Months After Sleeve Gastrectomy. Obesity (Silver Spring) 33: 2067-2075, 2025.","DOI":"10.1002\/oby.70006"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Hankosky ER, He X, Malik R, et al. Tirzepatide 10 and 15 mg versus semaglutide 2.4 mg in people with obesity or overweight with type 2 diabetes: An indirect treatment comparison. Diabetes Obes Metab 27: 3757-3765, 2025.","DOI":"10.1111\/dom.16401"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Banks A. GLP-1 Receptor Agonists and Eating Disorders - Cause for Concern. N Engl J Med 394: 1665-1667, 2026.","DOI":"10.1056\/NEJMp2600300"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/advpub\/0\/advpub_7502-26\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T04:13:36Z","timestamp":1785557616000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/advpub\/0\/advpub_7502-26\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":22,"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.7502-26","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"7502-26"}}